Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of randomised clinical trials impacted by COVID-19 and force majeure events.|
|Full bibliographic reference||Leung TH, Ho JC, El Helali A, Vokes EE, Wang X, Pang H. New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach. Ann Transl Med.2023;11(1):2.|
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Abstract, Harms/adverse effects/safety data, Intervention (exposure), Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.)|
|Record last updated on||May 16, 2023|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.